• Wed. Sep 11th, 2024

Sen. Durbin reintroduces Dietary Supplement Listing Act

Sen. Durbin reintroduces Dietary Supplement Listing Act

“FDA—and consumers—should know what dietary supplements are on the market and what ingredients are included in them,” Sen. Durbin shared in a statement issued July 29. “This is FDA’s most basic function, and the first step to protecting consumers.”

He and other proponents of the listing, including FDA​, assert that when Congress passed the Dietary Supplement Health and Education Act (DSHEA) of 1994, the absence of a provision requiring companies to register their products with FDA left the agency without the information needed to properly understand or oversee a market that has grown from $4 billion to more than $50 billion in sales over the last 30 years.

“There are more than one hundred thousand products on the market, but we don’t know critical information about most of them,” Sen. Durbin added. “Americans deserve a transparent supplement market, and it’s past time that we deliver it for them.”

The senator previously pushed for a mandatory product listing (MPL) in 2022, but legislative attempts ultimately failed to pass Congress.

What’s in the legislation

If passed this time around, the act would require companies to provide FDA with product names, a list of all ingredients, an electronic copy of the label, allergen statements, health and structure/function claims and other information about their products. This information would be made public to Americans through an electronic database. 

The statement from Sen. Durbin’s office highlighted that FDA received more than 2,000 adverse event reports related to dietary supplements in 2023 but that the agency estimated the actual annual number to be closer to 50,000 due to underreporting. 

link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *